TECLens

New York, United States

TECLens develops technology to treat keratoconus and correct vision problems.

$9.3M raised

Feb 2025

Series A

Top Investors

Johnson & Johnson Innovation JJDCSunmed CapitalYonjin VentureRimonci Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has TECLens raised?

TECLens has raised $9.3M in total funding. The most recent round was Series A. The last funding was announced in February 2025.

Who are TECLens's investors?

TECLens's investors include Johnson & Johnson Innovation JJDC, Sunmed Capital, Yonjin Venture, Rimonci Capital.

Where is TECLens headquartered?

TECLens is headquartered in New York, United States.

What does TECLens do?

TECLens develops technology to treat keratoconus and correct vision problems.

What stage is TECLens at?

TECLens is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 11, 2025.

MLA

"TECLens — Funding & Investors." VCBacked, February 11, 2025, https://www.vcbacked.co/company/teclens. Accessed June 7, 2026.

APA

VCBacked. (2025). TECLens — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/teclens

Wikipedia (cite web)

{{cite web |title=TECLens — Funding & Investors |url=https://www.vcbacked.co/company/teclens |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 11, 2025.